Effectiveness of anti-interleukin 23 biologic drugs in psoriasis patients who failed anti-interleukin 17 regimens. A real-life experience.

Bonifati, Claudio; Morrone, Aldo; Cristaudo, Antonio; Graceffa, Dario

Bonifati, Claudio; Morrone, Aldo; Cristaudo, Antonio; Graceffa, Dario.

Afiliación

Bonifati C; Department of Clinical Dermatology; Center for the Study and Treatment of Psoriasis, San Gallicano Dermatological Institute, IRCCS, Rome, Italy.
Morrone A; Scientific Direction, San Gallicano Dermatological Institute IRCCS, Rome, Italy.
Cristaudo A; Department of Clinical Dermatology; Center for the Study and Treatment of Psoriasis, San Gallicano Dermatological Institute, IRCCS, Rome, Italy.
Graceffa D; Department of Clinical Dermatology; Center for the Study and Treatment of Psoriasis, San Gallicano Dermatological Institute, IRCCS, Rome, Italy.

Dermatol Ther ; 34(1): e14584, 2021 01.

Article en En | MEDLINE | ID: mdl-33236471

Asunto(s)

Productos Biológicos; Psoriasis; Humanos; Interleucina-17; Interleucina-23; Psoriasis/diagnóstico; Psoriasis/tratamiento farmacológico

Palabras clave

anti-interleukin 17; anti-interleukin 23; biologics; psoriasis; switch

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Psoriasis / Productos Biológicos Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Dermatol Ther Asunto de la revista: DERMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google